Axonics Inc (AXNX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AXNX Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Axonics Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent239.45
Short-term Investments, Total105.77
Cash & Short-term Investments344.00
Accounts receivable62.64
Inventories113.86
Prepaid Expense And Other Assets Current4.18
Total Current Assets525.91
Equipment/Property/Plant Net0.00
Goodwill net104.55
Intangible Assets78.45
Long-term investments22.08
Other Assets, Noncurrent45.00
Total Assets774.17
Liabilities
Accounts Payable, Current AC20.11
Accrued Liabilities, Current41.70
Other Liabilities, Current2.61
Total Current Liabilities64.42
Total Long-term Debt0.00
Other liabilities, Noncurrent45.26
Operating Lease Liability Current2.61
Operating Lease Liability Noncurrent29.90
Deferred Income Tax Liabilities Net15.36
Total Liabilities109.68
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,063.19
Retained Earnings / Accumulated Deficit-392.59
Other Equity-6.11
Common Stockholder's Equity664.49
Total Stockholder's Equity664.49
Liabilities & Stockholder's Equity774.17
4 historic quarters locked

Sign in to unlock the full Axonics Inc balance sheet history.

About Axonics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001603756-24-000077

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.